4
Changes in Ownership
CG Oncology, Inc. Filed Acc 0000950170-25-005359
Director sold 1,000 shares at $29.66 ($29,660)
- Director acquired 1,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| POST LEONARD E Director | 2025-01-13 | Option exercise 10b5-1 | +1,000 | $0.60 | $600 | 1,000 | D: show line 1 in the form |
| POST LEONARD E Director | 2025-01-13 | Sale 10b5-1 | −1,000 | $29.66 | $29,660 | 0 | D: show line 2 in the form |
| Open-market sales · 1,000 sh · avg $29.66 · $29,660 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| POST LEONARD E Director | 2025-01-13 | Option exercise · Director Stock Option (right to buy) 10b5-1 | −1,000 | 132,077 | D: show line 3 in the form |
Loading xslF345X05/ownership.xml…